Live Chat

Neonatal PPHN: A Life-Threatening Risk for Your Child

Did you know that selective serotonin reuptake inhibitors (SSRIs) like Lexapro (escitalopram) are responsible for measurably increasing the probability that an infant will develop persistent pulmonary hypertension (PPHN)?

 

Thousands of pregnant women – many of whom regularly take an SSRI like Lexapro to treat their depression – don’t realize that the first trimester of their pregnancy is a critical risk period for neonatal PPHN. And, perhaps most importantly, many families don’t understand how serious the consequences of continuing their SSRI prescription can be. PPHN, a birth defect in which high blood pressure in the child’s lungs prevent proper oxygenation of the blood, is a life-threatening condition.

 

For many of the women, children, and families who have suffered as a result of an SSRI prescription, the attorneys at Fears Nachawati are prepared to make a measurable difference in their lives. Thanks to our experience and expertise, we’re prepared to take your SSRI claim from preliminary negotiations all the way to final settlement. If you or your loved one has suffered as a result of SSRI-induced PPHN, you should give us a call. For a free consultation, call us at 1.866.545.8364 or email mn@fnlawfirm.com

Categories
Drug Litigation

Neonatal PPHN: A Life-Threatening Risk for Your Child